WEST PHARMACEUTICAL SERVICES, INC. Proceeds from Issuance of Debt
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Proceeds from Issuance of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for the quarter ending 2025-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for the quarter ending 2024-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for the quarter ending 2024-09-30 was $129.70M.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for fiscal 2024 was $164.70M.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for fiscal 2023 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of debt for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $0.00 10-Q · filed 2025-10-23 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-24 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $129.70M derived: sum of 2 quarters · filed 2026-02-17 | $164.70M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $129.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $164.70M 10-Q · filed 2025-10-23 | ||
| 2024-06-30 | $35.00M 10-Q · filed 2025-07-24 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |